Ishitsubo, Naoki
Oguro, Shinji
Shimahashi, Hirotoshi
Kawanishi, Masato
Adachi, Takeshi
Mitsuda, Kenji
Ishibashi, Nobuyuki
Funding for this research was provided by:
Nippon Zoki Pharmaceutical
Article History
Accepted: 16 October 2023
First Online: 8 December 2023
Declarations
:
: All authors are employees of Nippon Zoki Pharmaceutical Co., Ltd. The authors are also listed as co-inventors on patent applications filed by Nippon Zoki Pharmaceutical Co., Ltd.
: The pharmacokinetic studies were conducted under contract with Nippon Zoki Pharmaceutical Co., Ltd., by the following research organizations, with approval from their ethical review committees: Inveresk Research (approval date: January 11, 2003), SOUSEIKAI Hakata Clinic (approval date: May 11, 2019) and SOUSEIKAI Nishi Kumamoto Hospital (approval date: May 11, 2019). All procedures in these studies were performed in accordance with the 1964 Helsinki Declaration (and its amendments).
: All participants provided written informed consent to participate.
: Not applicable.
: Study conception: all authors. Study design: NI, SO, HS, MK, TA and KM. Data acquisition: NI, SO, HS, MK, TA and KM. Data analysis and interpretation: NI, HS and TA. Drafting of the manuscript: NI, HS, MK, TA and KM. Critical revision: all authors. Final approval: all authors. Accountable for the accuracy and integrity of the work: all authors.
: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
: Not applicable.